Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,014 public trials 2,030 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

NCT04875195

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +8 more
Locations
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site Torrance, California, United States
  • Tulane Medical Center ( Site 0110) New Orleans, Louisiana, United States
  • Anne Arundel Medical Center-Anne Arundel Oncology and Hematology ( Site 0125) Annapolis, Maryland, United States
  • Hospital Erasto Gaertner ( Site 1703) Curitiba, Paraná, Brazil
View all 27 locations
View Trial Details
Completed

Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

NCT00310037

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Illinois CancerCare - Bloomington Bloomington, Illinois, United States
  • St. Joseph Medical Center Bloomington, Illinois, United States
  • Graham Hospital Canton, Illinois, United States
View all 48 locations
View Trial Details
Completed

ASP8374 + Cemiplimab in Recurrent Glioma

NCT04826393

Conditions
Astrocytoma, Glioblastoma, Glioma, +16 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Hospital of the University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

NCT02879643

Conditions
ALL, Childhood, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • The Children's Hospital, University of Colorado Aurora, Colorado, United States
View all 35 locations
View Trial Details
Completed

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

NCT01592370

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Local Institution - 0035 Clovis, California, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0017 Aurora, Colorado, United States
View all 43 locations
View Trial Details

Related conditions